About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Alleviant ALLAY-HF Study

NCT05685303·93 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Jennifer Olson
CONTACT
+1 612 327 2741 jen.olson@alleviantmedical.com

Lead

Alleviant Medical, Inc.

Age

40–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Symptomatic HFpEF/HFmrEF with LVEF greater than or equal to 40%
2. NYHA Class II, III or ambulatory IV
3. Exercise right heart catheterization\*
1. Elevated left atrial pressure during exercise right heart catheterization (greater than or equal to 25 mmHg)
2. Exercise PVR \< 1.8 WU
4. Ongoing stable GDMT

You may not be if

1. Advanced heart failure
2. Presence of a pacemaker
3. Evidence of right heart dysfunction

The record

StatusRecruiting

PhaseNo phase

Taking part700

StartedJan 2023

UpdatedAug 14, 2026

Conditions

Where93

Arizona Cardiovascular Research Center
Phoenix, Arizona, United States
HonorHealth
Scottsdale, Arizona, United States
Pima Heart and Vascular
Tucson, Arizona, United States

Clareo Health | Alleviant ALLAY-HF Study